Markets:

Overview

News

Currencies

International

Treasuries

Femasys Inc. - Common Stock (NQ:FEMY)

2.655 -0.295 (-10.00%)

Streaming Delayed Price Updated: 3:37 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Femasys Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 27, 2023

Via Benzinga

Why Is Femasys (FEMY) Stock Up 150% Today? ↗

July 27, 2023

With Femasys announcing a notice of allowance for its patent application, FEMY stock soared on its innovative birth control solution.

Via InvestorPlace

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

What's Going On Femasys Shares Today? ↗

July 27, 2023

Femasys Inc (NASDAQ: FEMY) shares are trading higher after the company announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for

Via Benzinga

Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results ↗

July 27, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 35,573.49 while the NASDAQ...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 27, 2023

Via Benzinga

Why Tivic Health Systems Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket ↗

July 10, 2023

Gainers Nanobiotix S.A. (NASDAQ: NBTX) shares surged 59.3% to $8.02 in pre-market trading after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 27, 2023

Via Benzinga

Chardan Capital Maintains Buy Rating for Femasys: Here's What You Need To Know ↗

March 31, 2023

Via Benzinga

Femasys's Return On Capital Employed Overview ↗

March 31, 2023

Via Benzinga

Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 10, 2023

Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 26, 2023

Via Benzinga

Why Femasys Shares Are On The Move Monday ↗

June 26, 2023

Femasys Inc (NASDAQ: FEMY) shares are trading higher Monday after the company announced that it received an Investigational Device Exemption (IDE) approval from the FDA to evaluate FemBloc

Via Benzinga

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 26, 2023

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 26, 2023

Via Benzinga

Femasys Announces FDA Approval of its IDE for the Pivotal Clinical Trial of FemBloc Permanent Birth Control, a Non-Surgical Alternative for Women

June 26, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Replaces Two Board Members with Seasoned Industry Leaders in the Life Sciences

June 15, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023

June 14, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys’ FemCath Intrauterine Catheter Receives Product Approval in Canada

June 08, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Announces Financial Results for the First Quarter Ended March 31, 2023

May 11, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

May 11, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys’ FemCerv Endocervical Tissue Sampler for Cervical Cancer Diagnosis Receives Product Approval in Canada

May 03, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. to Showcase FemCerv at the Annual Meeting for the American Society for Colposcopy and Cervical Pathology

May 01, 2023

From Femasys Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 24, 2023

Via Benzinga

Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results ↗

April 19, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Femasys Announces $3.9 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

April 19, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys’ FemaSeed Localized Directional Insemination for Infertility Receives Product Approval in Canada

April 18, 2023

From Femasys Inc.

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.